Physician profile
Mikhail Y Ivanovsky
NPI 1598810244
$1,221.99
in general payments reported to CMS, 2019-2025
20 companies · $80.60 in 2025
The $80.60 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $42.29 · 2021: $124 · 2022: $75.99 · 2023: $77.64 · 2024: $433 · 2025: $80.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $426.69 | 2019-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $163.43 | 2021-2024 | Intellis Adaptivestim |
| Averitas Pharma INC. | $106.04 | 2024 | Qutenza |
| Allergan, INC. | $84.98 | 2019-2021 | |
| Tersera Therapeutics LLC | $73.86 | 2019 | |
| Pfizer INC. | $53.40 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $48.50 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.43 | 2019 | |
| Biodelivery Sciences International, INC. | $30.63 | 2019-2021 | |
| Depuy Synthes Sales INC. | $30.02 | 2022 | |
| Pacira Therapeutics, INC. | $20.09 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.31 | 2025 | |
| Nalu Medical, INC. | $17.33 | 2022 | |
| Arbor Pharmaceuticals, INC. | $17.28 | 2021 | |
| Stimwave Technologies Incorporated | $16.65 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $16.17 | 2022 | |
| Grt US Holding, INC. | $14.42 | 2021 | |
| Daiichi Sankyo INC. | $14.26 | 2019 | |
| Boston Scientific Corporation | $13.03 | 2023 | Wavewriter Alpha Prime 16 |
| Forte Bio-Pharma LLC | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mikhail Ivanovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.